Skip to content
Clinical Trials – home
Shanghai Henlius Biotech Inc.
Sponsor

Shanghai Henlius Biotech Inc.

Building 1 Room 901 9th Floor, No 367 Shengrong Road, Shanghai Pilot Free Trade Zone, 201210

About the sponsor

Clinical development activity includes treatment research in locally advanced and metastatic gastroesophageal junction cancer and gastric cancer, with attention to HER2-directed therapy and combination regimens used in first-line care.

  • HER2-positive gastric malignancies
  • Metastatic gastric cancer
  • Gastroesophageal junction cancer

Research in this area is centered on antibody-based treatment strategies integrated with established chemotherapy backbones and immunotherapy-relevant combinations.

About Specializations

Shanghai Henlius Biotech Inc. runs clinical trials in conditions such as Non-small cell lung cancer, Gastric cancer, Oesophageal carcinoma, Oesophageal cancer metastatic, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:HLX43
  • Sponsor:Shanghai Henlius Biotech Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Shanghai Henlius Biotech Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Shanghai Henlius Biotech Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.